Trials / Conditions / Salivary Gland Cancers
Salivary Gland Cancers
5 registered clinical trials studyying Salivary Gland Cancers — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | PDO Based Drug Sensitive Test in R/M SGC NCT06686979 | Huashan Hospital | — |
| Recruiting | Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers NCT05884320 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (T NCT02568267 | Hoffmann-La Roche | Phase 2 |
| Completed | Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14 NCT02857712 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 2 |
| Completed | A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands NCT01678105 | Ontario Clinical Oncology Group (OCOG) | Phase 2 |